World's Best Scientists 2026 revealed!
Eiji Matsuura

Eiji Matsuura

D-Index & Metrics

Immunology

D-Index
65
Citations
15052
World Ranking
2848
National Ranking
119

Eiji Matsuura publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eiji Matsuura sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 315 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eiji Matsuura D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eiji Matsuura sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Eiji Matsuura is affiliated with Okayama University in Japan. Their research spans multiple fields with a strong focus on Medicine and Biochemistry, Genetics and Molecular Biology. Within these fields, their work often intersects with subfields including Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Rheumatology, and Biochemistry.

The scientist's work concentrates on various specialized topics. Key research areas include:

  • Radiopharmaceutical Chemistry and Applications
  • Boron Compounds in Chemistry
  • Boron and Carbon Nanomaterials Research
  • Atherosclerosis and Cardiovascular Diseases
  • Systemic Lupus Erythematosus Research
  • Eicosanoids and Hypertension Pharmacology
  • Nanoplatforms for cancer theranostics

Frequent venues for publication in their research career comprise:

  • Cells
  • Heliyon
  • Diabetes Research and Clinical Practice
  • PLoS ONE
  • Journal of Pharmaceutical Sciences

Eiji Matsuura has collaborated regularly with several co-authors, including:

  • Rani Sauriasari
  • Xian Wen Tan
  • Andisyah Putri Sekar
  • Kazuko Kobayashi
  • Takashi Ohtsuki

Among recent publications authored or co-authored by Eiji Matsuura are:

  • "Lactosome-Conjugated siRNA Nanoparticles for Photo-Enhanced Gene Silencing in Cancer Cells," 2021, Journal of Pharmaceutical Sciences
  • "Role of urinary H2O2, 8-iso-PGF2α, and serum oxLDL/β2GP1 complex in the diabetic kidney disease," 2022, PLoS ONE
  • "Antioxidative attributes of rice bran extracts in ameliorative effects of atherosclerosis-associated risk factors," 2020, Heliyon
  • "Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect," 2022, Cells
  • "Identification and visualization of oxidized lipids in atherosclerotic plaques by microscopic imaging mass spectrometry-based metabolomics," 2020, Atherosclerosis

Best Publications

  • Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease.

    Eiji Matsuura;Yoshiko Igarashi;Masao Fujimoto;Kenji Ichikawa

  • Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

    Eiji Matsuura;Yoshiko Igarashi;Tatsuji Yasuda;Douglas A. Triplett

  • Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

    Yehuda Shoenfeld;Roberto Gerli;Andrea Doria;Eiji Matsuura

  • Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.

    E Matsuura;Y Igarashi;M Fujimoto;K Ichikawa

  • Involvement of β2‐glycoprotein I and anticardiolipin antibodies in oxidatively modified low‐density lipoprotein uptake by macrophages

    Y. Hasunuma;Eiji Matsuura;Z. Makita;T. Katahira

  • Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.

    Yasuhito Honda;Yoshio Kuroki;Eiji Matsuura;Hisato Nagae

  • Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.

    Tatsuya Atsumi;Masahiro Ieko;Maria L. Bertolaccini;Kenji Ichikawa

  • A role for interleukin-2 trans -presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy

    Simone C Wuest;Jehad H Edwan;Jayne F Martin;Sungpil Han;Sungpil Han

  • Oxidation of LDL and its clinical implication.

    Eiji Matsuura;Graham R.V. Hughes;Munther A Khamashta

  • Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

    Akito Tsutsumi;Eiji Matsuura;Kenji Ichikawa;Atsushi Fujisaku

  • Circulating oxidized LDL forms complexes with β2-glycoprotein I implication as an atherogenic autoantigen

    Kazuko Kobayashi;Makoto Kishi;Tatsuya Atsumi;Maria L. Bertolaccini

  • Chemical Xenobiotics and Mitochondrial Autoantigens in Primary Biliary Cirrhosis: Identification of Antibodies against a Common Environmental, Cosmetic, and Food Additive, 2-Octynoic Acid

    Katsushi Amano;Patrick S C Leung;Roman Rieger;Chao Quan

  • Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis

    Eiji Matsuura;Kazuko Kobayashi;Masako Tabuchi;Luis R. Lopez

  • Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome.

    Y Hashimoto;M Kawamura;K Ichikawa;T Suzuki

  • Are Anti–Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective?

    Yehuda Shoenfeld;Yehuda Shoenfeld;Ruihua Wu;Linda D. Dearing;Eiji Matsuura

  • beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome

    Kenji Ichikawa;Munther A. Khamashta;Takao Koike;Eiji Matsuura

  • A specific ligand for β2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages

    Kazuko Kobayashi;Eiji Matsuura;Qingping Liu;Jun Ichi Furukawa

  • Is atherosclerosis an autoimmune disease

    Eiji Matsuura;Fabiola Atzeni;Piercarlo Sarzi-Puttini;Maurizio Turiel

  • Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system

    Makoto Igarashi;Eiji Matsuura;Yoshiko Igarashi;Hisato Nagae

  • Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.

    Hiroyuki Takeya;Tatsuyuki Mori;Esteban C. Gabazza;Kenji Kuroda

Frequent Co-Authors

Takao Koike
Takao Koike Hokkaido University
Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Tatsuya Atsumi
Tatsuya Atsumi Hokkaido University
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Keiji Oguma
Keiji Oguma Okayama University
Yasuo Ikeda
Yasuo Ikeda Waseda University
Munther A. Khamashta
Munther A. Khamashta King's College London
Yoshio Kuroki
Yoshio Kuroki Sapporo Medical University
Hirofumi Makino
Hirofumi Makino Okayama University
Miri Blank
Miri Blank Tel Aviv University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related online degrees can open up diverse career opportunities in healthcare and research. One popular pathway is pursuing an accelerated nurse practitioner program. These programs offer a fast-tracked route for healthcare professionals aspiring to advance their clinical roles with a focus on patient care and immunological conditions.

For individuals without a nursing background, starting with the best online RN programs for non nurses can provide a solid foundation in nursing fundamentals while accommodating busy lifestyles. These programs ensure non-nurses gain the essential clinical skills needed to progress toward specialized immunology or healthcare roles.

Additionally, if time is a constraint, many students find 12-month accelerated nursing programs beneficial. These intensive programs allow learners to swiftly acquire a Bachelor of Science in Nursing degree and start applying immunology knowledge in clinical settings.

Those seeking entry-level positions might consider exploring which LPN programs are easiest to get into. Licensed Practical Nurse programs often serve as stepping stones to build practical experience before advancing to higher immunology-focused degrees.

Best Scientists Citing Eiji Matsuura

Trending Scientists